Numbing injection may ease pain after incontinence surgery
NCT ID NCT07429019
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether injecting a numbing medicine (bupivacaine) into the surgical site during sling surgery for stress urinary incontinence can reduce pelvic and thigh pain after the operation. Sixty women will be randomly assigned to receive either the numbing medicine or a placebo (salt water) injection. Their pain levels will be checked within 24 hours, at one month, and at six months after surgery to see if the injection helps with both short-term and long-term pain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 60 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Jul 2026
An estimate. Start dates often move.
- Expected to finish
-
Oct 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Female participants only
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Women aged 18 years or older * Scheduled to undergo vaginal surgery including TVT or TVT-O procedure for stress urinary incontinence * Able and willing to provide written informed consent * Willing to complete postoperative follow-up assessments for at least 6 months Exclusion Criteria: * Planned concomitant abdominal, laparoscopic, or robotic surgery * Pre-existing chronic pelvic pain * Diagnosis of fibromyalgia * Diagnosis of endometriosis * Inability to complete follow-up assessments * Inability to provide informed consent
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Chronic pain syndrome are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Garmin watch may help new moms run without leaks
- Shoes that train your pelvic floor without you knowing
- Can your own blood help stop leakage? a new trial investigates
- Could a single magnesium dose tame Surgery's blood pressure swings?
- Virtual reality yoga may calm patients before a painful heart surgery step
- Can a short CBT session curb Post-Surgery opioid dependence?